Asia Pacific Blood Glucose Monitoring Market Size, Forecast, Share, Trends, Growth 2027
Market Highlights
A
number of devices for testing the glucose level in the blood are available in
the market such as invasive glucose monitoring devices, continuous glucose
monitoring devices (CGM), and flash glucose monitoring devices. These devices
are designed according to the type of diabetes, which help to identify the
blood glucose level within the specified target range and hence help you to
track your diet accordingly. Growing awareness regarding the devices in
developing countries has fueled the demand for these devices in Asia Pacific
region.
According
to the American Diabetes Association, the blood glucose levels for an adult
without diabetes is below 100 mg/dl before meals and fasting, and is less than
140 mg/dl two hours after a meal.
Diabetes
is one of the leading causes of premature death and disability. It can be
managed effectively if it diagnosed at early stage. However, if left untreated,
it can lead to various complications such as heart disease, stroke, kidney
damage, and nerve damage.
The Asia Pacific blood glucose monitoring market size is expected to grow at a CAGR of 10% during the forecast period
2017-2021.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/632
Regional
Analysis
China
dominates the Asia Pacific blood glucose monitoring market owing to well-developed
technology, increasing patient population with diabetes, high health care
spending, and increasing government support for research & development.
According to WHO, 110 million people have with diabetes in China.
India
is the second leading country having a large number of diabetic patient
population in Asia Pacific. According to International Diabetes Federation,
over 69.1 million people in 2015 had diabetes in India. Diabetes is one of the
major diseases in India. Over 50 million people have diabetes in India.
Furthermore,
countries such as Japan, Australia, and the Republic of Korea are showing a
considerable growth in the blood glucose monitoring market.
However,
increasing awareness, and development of the treatment technology is fuelling
the demand for the blood glucose monitoring devices in countries like South
Korea and India.
Segmentation
The
blood glucose monitoring devices market is segmented on the basis of product
type, application, and end user. On the basis of the product type, it is segmented
into invasive glucose monitoring devices, continuous glucose monitoring devices
(CGM), flash glucose monitoring devices, and others. On the basis of the
application, it is segmented into type 1 diabetes, type 2 diabetes, and others.
On the basis of the end user, it is segmented into diagnostic centers,
hospitals, clinics, research centers, and home care diagnostics.
Asia Pacific Blood Glucose Monitoring Market
Players
·
Abbott Laboratories
·
Arkay
·
Inc.
·
Bayer Healthcare AG
·
F. Hoffmann-La Roche
·
Goldsite Diagnostics Inc.
·
GlySure Ltd
·
Sphere Medical
·
Dexcom
·
LifeScan
among others are some key companies in the
Asia Pacific Blood Glucose Monitoring that are listed by MRFR for market
research.
Browse Detailed TOC with COVID-19 Impact
Analysis at:
https://www.marketresearchfuture.com/reports/asia-pacific-blood-glucose-monitoring-market-632
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Comments
Post a Comment